JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 9, 2007; DOI: 10.1124/jpet.107.121038


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.121038v1
322/2/668    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirano, K.
Right arrow Articles by Kanaide, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirano, K.
Right arrow Articles by Kanaide, H.


Received for publication February 7, 2007.
Revised May 3, 2007.
Accepted for publication May 8, 2007.

Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells

Katsuya Hirano 1, Namie Nomoto 1, Mayumi Hirano 1, Fumi Momota 1, Akiko Hanada 1, Hideo Kanaide 1*

1 Graduate School of Medical Sciences, Kyushu University

* Address correspondence to: E-mail: kanaide{at}molcar.med.kyushu-u.ac.jp

Abstract

Proteinase-activated receptor 1 and 4 (PAR1 and PAR4) are the major receptors mediating thrombin-induced NO production in endothelial cells. The intracellular signaling following their activation still remains to be elucidated. The present study provides the first evidence for the distinct Ca2+ requirement for the NO production between PAR1 and PAR4. The activation of PAR1 by the activating peptide (PAR1-AP) elevated [Ca2+]i and activated NO production in porcine aortic and human umbilical vein endothelial cells, while it had little effect on bovine aortic endothelial cells. PAR4 activation by PAR4-AP consistently induced NO production without an appreciable [Ca2+]i elevation in three types of endothelial cells. The PAR1-mediated NO production was significantly inhibited by BAPTA, while the PAR4-mediated NO production was resistant. NO production following the PAR1 and PAR4 activation was significantly inhibited by pertussis toxin, but it was resistant to a G{alpha}q/11 inhibitor, YM254890. However, YM254890 abrogated the PAR1-mediated Ca2+ signal. PAR4-mediated NO production was substantially inhibited by the inhibitors of phosphotidylinositol-3 kinase and Akt, and also by the dominant negative mutant of Akt. The PAR1-mediated NO production was relatively resistant to inhibitors of phosphotidylinositol-3 kinase. An immunoblot analysis revealed a transient increase in the phosphorylation of Akt and eNOS following the PAR4 stimulation. In conclusion, PAR1 and PAR4 engage distinct signal transduction mechanisms to activate NO production in vascular endothelial cells. PAR4 preferably activates G{alpha}i/o and induced NO production in a manner mostly independent of Ca2+ but dependent on the phosphotidylinositol-3 kinase-Akt pathway, while PAR1 activates both the Ca2+-dependent and independent mechanisms.


Key words: calcium, endothelial cells, nitric oxide, receptor, signal transduction, thrombin





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.